European experts publish recommendations for treatment of acute lymphoblastic leukemia in adults

FHS
March 1, 2024
11:00 am

The treatment of acute lymphoblastic leukemia in adults is extremely complex, lengthy and very stressful for patients.

Inflation reduction act boosts biologic drug venture financing over small molecules – Pharmaceutical Technology

Source: GlobalData, Pharma Intelligence Center, Deals Database (Accessed 21 March 2023). ©GlobalData. US-headquartered biotechs received an overall 19% ($48.9bn) more in venture financing for biologic

June 27, 2023

Common challenges when seeking market access for rare disease therapies

In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth & Strategy at AscellaHealth about the recurring challenges met when seeking

October 19, 2023

Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell transplantation (HSCT) remains the only widely accessible curative option for

December 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.